more

Cerner Corporation (CERN)

(Delayed Data from NSDQ)

$68.47 USD

+0.46 (0.68%)

Updated May 3, 2019 04:00 PM ET

After-Market: $68.46 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

Industry: NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Based in North Kansas City, MO, Cerner Corporation (CERN) provides healthcare information technology (HCIT) solutions worldwide. The company offers software and hardware solutions that give healthcare providers secure access to clinical, administrative and financial data in a short time. As of February 2018, its products were in use at more than 27,000 facilities around the world. The company had more than 28,000 employees globally, with over 13,000 in Kansas City, Missouri. More than 28,000 Cerner associates are currently employed in 26 countries worldwide

Here's Why You Should Retain NuVasive (NUVA) Stock for Now

by Zacks Equity Research Published on May 28,2019

Investor confidence in the stock is high on NuVasive's (NUVA) sturdy spine business.

medical

Here's Why You Should Hold on to Hill-Rom (HRC) Stock Now

by Zacks Equity Research Published on May 27,2019

Investor confidence in the stock is high on Hill-Rom's (HRC) recent acquisition of Voalte.

medical

Here's Why You Should Hold Varian Medical (VAR) Stock Now

by Zacks Equity Research Published on May 27,2019

Varian Medical (VAR) raises revenue guidance for 2019 encourages.

medical

Cerner (CERN) Up 9.3% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research Published on May 25,2019

Cerner (CERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CERNPositive Net Change

Moving Average Crossover Alert: Cerner

by Zacks Equity Research Published on May 07,2019

Cerner is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

CERNPositive Net Change

medical

Cerner (CERN) Earnings and Revenues Meet Estimates in Q1

by Zacks Equity Research Published on April 26,2019

Cerner (CERN) gains from Professional Services unit in first-quarter 2019. A decline in bookings raises concern.

CERN vs. TRHC: Which Stock Is the Better Value Option?

by Zacks Equity Research Published on April 25,2019

CERN vs. TRHC: Which Stock Is the Better Value Option?

Zacks.com featured expert Kevin Matras highlights: Ralph Lauren, Cerner, KeyW, Fifth Third and Energy Transfer

by Zacks Equity Research Published on April 23,2019

Zacks.com featured expert Kevin Matras highlights: Ralph Lauren, Cerner, KeyW, Fifth Third and Energy Transfer

medical

What's in Store for Tandem Diabetes' (TNDM) Q1 Earnings?

by Zacks Equity Research Published on April 23,2019

The roll-out of Tandem Diabetes' (TNDM) unique insulin pump platform viz. t:slim X2 with Basal-IQ technology is expected to drive the top line in first-quarter 2019.

Cerner (CERN) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research Published on April 22,2019

Top-line growth and solid show by Population Health, Revenue Cycle and IT Works are likely to aid Cerner (CERN) in Q1. However, expected decline in bookings is likely to be a dampener.

Bet on These 5 Stocks With Upgraded Broker Ratings Right Now

by Swayta Shah Published on April 22,2019

Brokers have a deeper understanding of stocks, industries and the overall economy. Thus, it is wise to follow their advice to ensure robust returns.

Cerner (CERN) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research Published on April 18,2019

Cerner (CERN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CERNPositive Net Change

Can Boston Scientific's (BSX) Steady Growth Aid Q1 Earnings?

by Zacks Equity Research Published on April 18,2019

We are optimistic about Boston Scientific's (BSX) IC business that will help maintain its impressive global growth trend in Q1 owing to an innovative portfolio and strong commercial teams.

Can Five Elements Drive Quest Diagnostics (DGX) Q1 Earnings?

by Zacks Equity Research Published on April 17,2019

Quest Diagnostics (DGX) seems in sync with its strategy to expedite growth and operational excellence.

Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings?

by Zacks Equity Research Published on April 16,2019

Despite ongoing customers' transition from HiSeq consumables to NovaSeq, Illumina's (ILMN) Q1 results are expected to gain from this high throughput suite.

Medidata (MDSO) Surges: Stock Moves 7.5% Higher

by Zacks Equity Research Published on April 16,2019

Medidata (MDSO) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

medical

Can Medical Devices Strength Drive Abbott (ABT) Q1 Earnings?

by Zacks Equity Research Published on April 15,2019

Abbott (ABT) expects high single-digit growth in Medical Devices' sales in first-quarter 2019 and continued double-digit growth in certain sub-segments.

Cerner and naviHealth Extend Partnership, Boost EHR Service

by Zacks Equity Research Published on April 15,2019

Cerner (CERN) and naviHealth coordinate to provide EHR offering that is expected to benefit health care providers in the form of affordable and accessible health care centered on the patient.